NCT07143591

Brief Summary

The aim of the study is to: . Assess the outcome of Supraventricular tachycardia , the most effective acute and long-term management strategies and recurrence rates of SVT .

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
1mo left

Started Aug 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Aug 2025Aug 2026

Study Start

First participant enrolled

August 1, 2025

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

August 20, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 27, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

September 2, 2025

Status Verified

August 1, 2025

Enrollment Period

11 months

First QC Date

August 20, 2025

Last Update Submit

August 26, 2025

Conditions

Supraventricular Tachycardia

Outcome Measures

Primary Outcomes (1)

  • Outcome of Supraventricular tachycardia in children and recurrence rates

    Assess the outcome of Supraventricular tachycardia , the most effective acute and long-term management strategies and recurrence rates of SVT .

    Baseline

Interventions

Not foundOTHER

No intervention

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All with the required criteria

You may qualify if:

  • Children aged greater than 1 month and up to 18 years
  • Diagnosis of supraventricular tachycardia (SVT) based on:
  • Clinical presentation
  • Electrocardiogram (ECG) findings

You may not qualify if:

  • Presence of structural heart disease
  • Incomplete clinical data
  • Lost to follow-up during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Hafeez Y, Quintanilla Rodriguez BS, Ahmed I, Grossman SA. Paroxysmal Supraventricular Tachycardia. 2024 Feb 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK507699/

    PMID: 29939521BACKGROUND

  • Nasir M, Sturts A, Sturts A. Common Types of Supraventricular Tachycardia: Diagnosis and Management. Am Fam Physician. 2023 Jun;107(6):631-641.

    PMID: 37327167BACKGROUND

MeSH Terms

Conditions

Tachycardia, Supraventricular

Condition Hierarchy (Ancestors)

TachycardiaArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Sameh Mounir Moussa Soliman

CONTACT

01001960035Samehmounir24@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric resident

Study Record Dates

First Submitted

August 20, 2025

First Posted

August 27, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

September 2, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share